logo
logo

Loyal raised $22M in Series B-2 funding led by Valor Equity Partners to expand operations and enhance R&D efforts.

Feb 27, 2025•5 months ago

Amount Raised

$22 Million

Atlanta

Investors

Collaborative FundValor Equity Partners

Description

Loyal, a clinical-stage animal health company based in San Francisco, raised $22M in its Series B-2 funding round. The funding, led by Valor Equity Partners and Collaborative Fund, aims to support the company's expansion and development of innovative drugs for dogs.

Company Information

Company

Loyal

Location

Atlanta, Georgia, United States

About

One of the first companies to offer end-to-end digital and AI-powered solutions spanning the entirety of the patient journey, Loyal is the preferred software solution for improved care utilization among the nation's leading health systems and hospitals. From selecting a provider best suited for them to closing the feedback loop on their experience, patients who engage with healthcare networks via our proprietary platform quite simply, tend to be more loyal. Learn how to streamline patients' navigation of your health system and network of clinical services at LoyalHealth.com.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People